NASDAQ
Milestone Pharmaceuticals Inc. (MIST) reported revenue of $1.55M and net income of $-63,058,000 for FY 2025, with a net profit margin of -4078.8%. Revenue represents total sales while net income is the profit remaining after all expenses. The relationship between them reflects overall profitability.
No price data available for this timeframe.